ACA11 overexpression increased the response to Btz in MM cells, as evidenced by both the higher slope of the relationship between cell number and Btz dose (Table 1), and the lower Btz dose (8.9 nmol/L, Table 1) required to kill 100% of cells overexpressing ACA11. This evidence concerns the gene SCARNA22 and Miyoshi myopathy.